LVMH: Ongoing Weakness Is Not A China-Related Issue -- Q3 Confirms Sell Rating

LVMH shares are down about 30% over 12 months, while its largest and highest-margin Fashion & Leather Goods segment posted a 5% organic sales decline in Q3, worsening the downtrend. Management cited China, but peer results suggest LVMH-specific weakness; recovery catalysts are not yet visible, and the stock remains rated Sell.

Analysis

The issue is earnings quality, not just China

A contraction in the largest, high-margin division can have an outsized effect on group profit: weaker volume and less favorable product mix may pressure operating leverage even if other divisions hold up. If peers are proving more resilient, that would shift the debate from a temporary China demand shock toward brand execution, product cadence, or customer mix—but the supplied evidence does not establish which explanation is correct. Verify like-for-like peer growth and regional/product disclosures before treating the weakness as company-specific.

Timing: Over the next 1–3 months, estimate revisions and the next detailed segment update matter more than the already-known share-price decline. Over 6–18 months, sustained underperformance could impair pricing power and widen the valuation gap versus luxury houses that retain stronger demand; a China-led category recovery could instead lift the whole group and squeeze shorts. The bearish thesis is falsified by improving Fashion & Leather Goods organic sales accompanied by stabilizing segment profitability, not merely better China commentary.

The drawdown raises the risk of chasing a crowded or already-discounted short. Without valuation, estimate-revision, and peer-comparison data, conviction is stronger on relative underperformance risk than on absolute downside.

Key Decisions for Investors

• Prefer a measured, beta-adjusted relative underweight in MC versus a basket of luxury peers such as Hermès and Richemont, rather than an outright short at current levels. Initiate only if the next update confirms continued segment weakness while comparable peers remain healthier; reduce or exit if MC’s segment sales and profitability stabilize. This limits broad luxury-demand exposure but retains company-specific downside.
• Near term, track sell-side earnings revisions, Fashion & Leather Goods organic sales and margin commentary, and peer regional/category disclosures. A broad-based luxury rebound would weaken the relative trade; persistent MC-specific deterioration would strengthen it.
• Do not add to an outright short solely on the past share-price decline. Reassess after the next results: the missing evidence is whether weakness is isolated to MC and whether segment profit is falling faster than sales. If the divergence is not confirmed, there may be no trade.